NDAINJECTIONINJECTABLE
Approved
May 1968
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 15h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HIPPURAN I 131 (Iodohippurate Sodium I-131) is a radiopharmaceutical diagnostic agent administered by injection for renal imaging and function assessment. This product is a radioactive tracer that localizes in the kidneys, enabling clinicians to visualize kidney perfusion and excretory function. It represents a legacy nuclear medicine diagnostic with established clinical utility in nephrology and urology.
LOE Approaching
Product approaching loss of exclusivity with minimal commercial momentum; brand teams are typically lean and focused on market defense rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HIPPURAN I 131 offers limited career growth potential given the product's mature lifecycle stage and approaching loss of exclusivity. Roles focus on defending market share and managing regulatory/operational continuity rather than driving innovation or commercial expansion.
Product ManagerField Sales Representative
Worked on HIPPURAN I 131 at PharmaLundensis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.